AIM IMMUNOTECH INC. Financing Interest Expense
AIM IMMUNOTECH INC. (AIM) reported Financing Interest Expense of $61.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Expense Statement › Interest Expense
us-gaap:FinancingInterestExpense · last filed 2019-04-01
- AIM IMMUNOTECH INC. financing interest expense for the quarter ending 2018-12-31 was $18.00K.
- AIM IMMUNOTECH INC. financing interest expense for the quarter ending 2018-09-30 was $18.00K.
- AIM IMMUNOTECH INC. financing interest expense for the quarter ending 2018-06-30 was $9.00K.
- AIM IMMUNOTECH INC. financing interest expense for the quarter ending 2018-03-31 was $16.00K.
- AIM IMMUNOTECH INC. financing interest expense for fiscal 2018 was $61.00K.
| Period end | Financing Interest Expense 3 month | Financing Interest Expense 6 month | Financing Interest Expense 9 month | Financing Interest Expense 12 month |
|---|---|---|---|---|
| 2018-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $36.00K derived: sum of 2 quarters · filed 2019-04-01 | $45.00K derived: sum of 3 quarters · filed 2019-04-01 | $61.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $27.00K derived: sum of 2 quarters · filed 2018-11-14 | $43.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $25.00K 10-Q · filed 2018-08-14 | ||
| 2018-03-31 | $16.00K 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |